Pancreatic Cancer Action Network's SPARK: A Cloud-Based Patient Health Data and Analytics Platform for Pancreatic Cancer

被引:3
|
作者
Abdilleh, Kawther [1 ]
Khalid, Omar [1 ]
Ladnier, Dennis [1 ]
Wan, Wenshuai [2 ]
Seepo, Sara [3 ]
Rupp, Garrett [3 ]
Corelj, Valentin [3 ]
Worman, Zelia F. [3 ]
Sain, Divya [3 ]
DiGiovanna, Jack [3 ]
Press, Bruce [4 ]
Chandrashekhar, Satty [5 ]
Collisson, Eric [6 ]
Cui, Karen Y. [7 ]
Maitra, Anirban [8 ]
Rejto, Paul A. [9 ]
White, Kevin P. [10 ]
Matrisian, Lynn [1 ]
Doss, Sudheer [1 ]
机构
[1] Pancreat Canc Act Network, 1500 Rosecrans Ave,Ste 200, Manhattan Beach, CA 90266 USA
[2] Tempus, Chicago, IL USA
[3] Velsera, Charlestown, MA USA
[4] ZS, Princeton, NJ USA
[5] Boston Consulting Grp Inc, New York, NY USA
[6] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Astra Zeneca, Rockville, MD USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Pfizer, La Jolla, CA USA
[10] Natl Univ Singapore, Singapore, Singapore
来源
关键词
D O I
10.1200/CCI.23.00119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEPancreatic cancer currently holds the position of third deadliest cancer in the United States and the 5-year survival rate is among the lowest for major cancers at just 12%. Thus, continued research efforts to better understand the clinical and molecular underpinnings of pancreatic cancer are critical to developing both early detection methodologies as well as improved therapeutic options. This study introduces Pancreatic Cancer Action Network's (PanCAN's) SPARK, a cloud-based data and analytics platform that integrates patient health data from the PanCAN's research initiatives and aims to accelerate pancreatic cancer research by making real-world patient health data and analysis tools easier to access and use.MATERIALS AND METHODSThe SPARK platform integrates clinical, molecular, multiomic, imaging, and patient-reported data generated from PanCAN's research initiatives. The platform is built on a cloud-based infrastructure powered by Velsera. Cohort exploration and browser capabilities are built using Velsera ARIA, a specialized product for leveraging clinicogenomic data to build cohorts, query variant information, and drive downstream association analyses. Data science and analytic capabilities are also built into the platform allowing researchers to perform simple to complex analysis.RESULTSVersion 1 of the SPARK platform was released to pilot users, who represented diverse end users, including molecular biologists, clinicians, and bioinformaticians. Included in the pilot release of SPARK are deidentified clinical (including treatment and outcomes data), molecular, multiomic, and whole-slide pathology images for over 600 patients enrolled in PanCAN's Know Your Tumor molecular profiling service.CONCLUSIONThe pilot release of the SPARK platform introduces qualified researchers to PanCAN real-world patient health data and analytical resources in a centralized location. Access & use real-world #pancreaticcancer #healthdata through @PanCAN's SPARK cloud-based platform.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Pancreatic Cancer Action Network: Advance Research, Support Patients, and Create Hope
    Fleshman, Julie
    JOURNAL OF ONCOLOGY PRACTICE, 2009, 5 (02) : 98 - 98
  • [32] Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer
    Wang, Yu
    Cui, Jiujie
    Wang, Liwei
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
  • [33] Development of patient-derived platform to assess activity of anticancer agents in pancreatic cancer
    Khazak, Vladimir
    Skobeleva, Natalia
    Beglyarova, Natalia
    Banina, Eugenia
    Lysenko, Elena
    Astsaturov, Igor
    Jablonski, Sandra A.
    Weiner, Louis M.
    Serebriiskii, Ilya
    Proia, David A.
    CANCER RESEARCH, 2015, 75
  • [34] Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
    Watanabe, Sadanori
    Yogo, Akitada
    Otsubo, Tsuguteru
    Umehara, Hiroki
    Oishi, Jun
    Kodo, Toru
    Masui, Toshihiko
    Takaishi, Shigeo
    Seno, Hiroshi
    Uemoto, Shinji
    Hatano, Etsuro
    BMC CANCER, 2022, 22 (01)
  • [35] Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
    Sadanori Watanabe
    Akitada Yogo
    Tsuguteru Otsubo
    Hiroki Umehara
    Jun Oishi
    Toru Kodo
    Toshihiko Masui
    Shigeo Takaishi
    Hiroshi Seno
    Shinji Uemoto
    Etsuro Hatano
    BMC Cancer, 22
  • [36] Patient and Liaison Services (PALS): Pancreatic cancer survivor and caregiver support network
    Duff, ME
    Fleshman, JM
    Kim, P
    Nesbitt, JP
    Ayele, MA
    Spangler, SL
    Zieger, JA
    PSYCHO-ONCOLOGY, 2005, 14 (01) : S29 - S29
  • [37] Online Databases for Taxonomy and Identification of Pathogenic Fungi and Proposal for a Cloud-Based Dynamic Data Network Platform
    Prakash, Peralam Yegneswaran
    Irinyi, Laszlo
    Halliday, Catriona
    Chen, Sharon
    Robert, Vincent
    Meyer, Wieland
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (04) : 1011 - 1024
  • [38] VisComm: A cloud-based platform for accessing and creating scientific visualization for the pediatric cancer research community
    Finkelstein, David B.
    Madson, James
    Vacaroiu, Lucian
    Gout, Alexander M.
    Hirja, Leonard
    Sandor, Stephanie
    Thrasher, Andrew
    Reilly, Colleen
    Wang, Jian
    Chen, Xiaolong
    Zhou, Xin
    Zhang, Jinghui
    McLeod, Clay
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Spottitt Presents Cloud-based Geospatial Data Analysis on DNV GL's Veracity Platform
    不详
    GIM INTERNATIONAL-THE WORLDWIDE MAGAZINE FOR GEOMATICS, 2018, 32 (06): : 11 - 11
  • [40] Machine learning based detection of pancreatic tumors using the Dxcover® cancer platform
    Sala, Alexandra
    Cameron, James M.
    Jenkins, Cerys A.
    Barr, Hugh
    Christie, Loren
    Conn, Justin J.
    Evans, Thomas R.
    Harris, Dean A.
    Palmer, David S.
    Rinaldi, Christopher
    Theakstone, Ashton G.
    Baker, Matthew J.
    CANCER RESEARCH, 2022, 82 (12)